跳至主要内容
临床试验/IRCT20190107042264N1
IRCT20190107042264N1招募中3 期

The Effect of a formulation containing Boswellia Serrata extract on the Osteoarthritis patients’ pain alleviation and quality of life improvement and comparison with Placebo and Piroxicam Gel

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patient's presenting with knee pain with Osteoarthritis as a diagnosis
  • at least three months since diagnosis
  • Visual Analog Scale score must be more than 40 after stopping the treatment for 7 days
  • Lequesne functional Index more than 7 after stopping the treatment for 7 days
  • Patients must have the ability to stand and walk and to provide written and oral consent

排除标准

  • Allergy of any kind to Boswellia and any of it's derivatives
  • Patient's unresponsive to conventional treatment
  • Inflammatory Arthropathies
  • Hyperuricemia
  • Surgery planned
  • New injury in sight of OA
  • Intraarticular corticosteroid injection in the past 3 months
  • Liver or Renal Failure
  • History of gastric ulceration
  • Uncontrolled Hypertension
  • Congestive Heart Failure

研究者

相似试验